Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about PPAR-Γ: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
PPAR-Γ is a concept in neurodegeneration research. Key relationships include: activates, contributes to, inhibits. Associated with ALS, Als, Alzheimer. Connected to 136 entities in the SciDEX knowledge graph.
No AI portrait yet
| Name | PPAR-Γ |
| Key Genes/Proteins | AKT, ALZHEIMER, ALZHEIMER'S DISEASE, AMPK, AMYLOID, AND |
| Related Diseases | Als, ALS, Alzheimer |
| Related Pathways | Akt, Amyloid, Angiogenesis, Apoptosis |
graph TD
PPAR__["PPAR-Gamma"]
PPAR__ -->|"inhibits"| Als["Als"]
PPAR__ -->|"inhibits"| Ms["Ms"]
PPAR__ -->|"inhibits"| Tumor["Tumor"]
PPAR__ -->|"contributes to"| Inflammation["Inflammation"]
PPAR__ -->|"contributes to"| Alzheimer["Alzheimer"]
PPAR__ -->|"contributes to"| Neurodegeneration["Neurodegeneration"]
PPAR__ -->|"contributes to"| Neuroinflammation["Neuroinflammation"]
PPAR__ -->|"contributes to"| Dementia["Dementia"]
CD4["CD4"] -->|"inhibits"| PPAR__
CYTOKINES["CYTOKINES"] -->|"inhibits"| PPAR__
FOXP3["FOXP3"] -->|"inhibits"| PPAR__
NF__B["NF-KappaB"] -->|"inhibits"| PPAR__
TNF["TNF"] -->|"inhibits"| PPAR__
STAT3["STAT3"] -->|"inhibits"| PPAR__
IL_6["IL-6"] -->|"inhibits"| PPAR__
MICROGLIA["MICROGLIA"] -->|"contributes to"| PPAR__
MTOR["MTOR"] -->|"contributes to"| PPAR__
PHAGOCYTOSIS["PHAGOCYTOSIS"] -->|"inhibits"| PPAR__| Target | Relation | Type | Str |
|---|---|---|---|
| NF-κB | inhibits | protein | 0.80 |
| NF-κB | modulates | pathway | 0.80 |
| Diabetes | activates | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| Inflammation | activates | disease | 0.75 |
| PGC-1α | interacts_with | protein | 0.70 |
| PPAR | activates | gene | 0.70 |
| neurodegenerative disease | treats | disease | 0.70 |
| gene transcription | regulates | process | 0.70 |
| neurodegeneration | protects_against | process | 0.70 |
| Dementia | contributes_to | disease | 0.65 |
| Cardiovascular | activates | disease | 0.65 |
| Obesity | regulates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Neuroinflammation | contributes_to | disease | 0.65 |
| Neurodegeneration | contributes_to | disease | 0.65 |
| Tumor | contributes_to | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Atherosclerosis | activates | disease | 0.65 |
| Ms | activates | disease | 0.65 |
| Fibrosis | activates | disease | 0.65 |
| Cardiac | activates | disease | 0.65 |
| Cardiovascular | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Diabetes | therapeutic_target | disease | 0.65 |
| Sepsis | associated_with | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Alzheimer | therapeutic_target | disease | 0.65 |
| Ms | expressed_in | disease | 0.65 |
| Cirrhosis | activates | disease | 0.65 |
| ALS | associated_with | disease | 0.65 |
| Fibrosis | contributes_to | disease | 0.65 |
| Neuroinflammation | activates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Neurodegeneration | activates | disease | 0.65 |
| Neurodegeneration | protects_against | disease | 0.65 |
| Obesity | activates | disease | 0.65 |
| Hepatitis | activates | disease | 0.65 |
| Als | activates | disease | 0.65 |
| Multiple Sclerosis | associated_with | disease | 0.65 |
| Hypertension | activates | disease | 0.65 |
| Autoimmune | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Tumor | inhibits | disease | 0.65 |
| Als | inhibits | disease | 0.65 |
| Ms | inhibits | disease | 0.65 |
| NLRP3 | activates | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Betulinic Acid | activates | chemical | 0.80 |
| PPARGC1A | associated_with | gene | 0.80 |
| FKBP5 | regulates | gene | 0.80 |
| PPARG | encodes | gene | 0.70 |
| PPAR | activates | gene | 0.70 |
| NRF2 | activates | gene | 0.70 |
| AQP4 | activates | gene | 0.60 |
| AQUAPORIN-4 | associated_with | gene | 0.60 |
| ASTROCYTE | activates | gene | 0.60 |
| TNF | activates | gene | 0.60 |
| LRRK2 | activates | gene | 0.60 |
| PARKINSON | activates | gene | 0.60 |
| NLRP3 | activates | gene | 0.60 |
| PARKINSON'S DISEASE | activates | gene | 0.60 |
| CASPASE3 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| RUNX2 | expressed_in | gene | 0.60 |
| RNA | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| BCL2 | activates | gene | 0.60 |
| AND | activates | gene | 0.60 |
| APOPTOSIS | activates | gene | 0.60 |
| GLUT4 | activates | gene | 0.60 |
| HMGB2 | inhibits | gene | 0.60 |
| SIRT1 | inhibits | gene | 0.60 |
| CYTOKINES | associated_with | gene | 0.60 |
| CD4 | inhibits | gene | 0.60 |
| CYTOKINES | inhibits | gene | 0.60 |
| FOXP3 | inhibits | gene | 0.60 |
| PRKN | activates | gene | 0.60 |
| SNCA | activates | gene | 0.60 |
| TNF-Α | activates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| DJ-1 | activates | gene | 0.60 |
| PINK1 | activates | gene | 0.60 |
| PPAR | inhibits | gene | 0.60 |
| DEMENTIA | contributes_to | gene | 0.60 |
| ALZHEIMER | contributes_to | gene | 0.60 |
| P38 | contributes_to | gene | 0.60 |
| AMYLOID | inhibits | gene | 0.60 |
| ASTROCYTE | contributes_to | gene | 0.60 |
| IL-10 | activates | gene | 0.60 |
| NEURODEGENERATION | activates | gene | 0.60 |
| NEUROINFLAMMATION | activates | gene | 0.60 |
| NLR | activates | gene | 0.60 |
| IL-6 | activates | gene | 0.60 |
| NEUROINFLAMMATION | contributes_to | gene | 0.60 |
| MAPK | contributes_to | gene | 0.60 |
| MICROGLIA | contributes_to | gene | 0.60 |
| MTOR | contributes_to | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| No targeting hypotheses | |||
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning PPAR-Γ in their description or question text
No additional research found